Medical research focuses on AMD and dementia treatments

Medical research is advancing in the fields of age-related macular degeneration (AMD) and dementia. Regarding AMD, Professor Goran Petrovski of Oslo University Hospital notes that the condition affects the macula, which is essential for central vision. AMD is categorized into dry (atrophic) and wet (neovascular) forms. Dry AMD accounts for 85-90 percent of cases and develops slowly, while wet AMD involves abnormal blood vessel growth that can lead to rapid vision loss. Risk factors include age, genetics, and smoking, though lifestyle factors like a Mediterranean diet and physical activity may help.

In the field of dementia, there is an increasing prevalence among adults due to aging populations, but experts highlight that children can also be affected. While research has made progress, an effective cure for childhood dementia and other forms remains elusive. The Norwegian National Association (Nasjonalforeningen) is advocating for improved care services for patients and caregivers, alongside increased funding for research into the causes, diagnosis, and prevention of the disease.